Webinar: Idiopathic Normal Pressure Hydrocephalus, a treatable dementia?

Sponsored by: CODMAN Neuro

Focused on:

  • Diagnosis
  • Treatment

Date: 25 March

1335

Time: 2-3:30PM London/6-7:30PM Moscow

Don’t assume it’s Alzheimer’s or Parkinson’s… it could be NPH!

Don't assume it's Alzheimer's or Parkinson's... it could be iNPH!

It is estimated that 20% of iNPH patients are not diagnosed and only 15% are treated correctly*. iNPH is often confused with Alzheimer and Parkinson diseases but iNPH can be treated. iNPH patients after a shunt surgery can come back to normal life.

The Codman Neuro webinar is designed for interaction about idiopathic Normal Pressure Hydrocephalus. The aim is to share a complete description of the disease and how to diagnose and treat it. Our renowned and multi-disciplinary faculty will discuss their views and share their extensive experience with the audience.

The course is ideal for consultant physicians (all specialties) who want to learn and share their experiences with their peers.

Please join this webinar to learn more about differential diagnosis of iNPH.

Codman Neuro Mission: To deliver life-saving neuro solutions and support you can count on.
Codman Neuro, a division of Johnson & Johnson, is a global neuroscience company that develops and markets a wide range of devices and solutions for the diagnosis and treatment of neurological disorders.

*Codman Data on file

Presented by

Doctor Joanna Iddon,

Neuropsychologist, Central London, UK

Dr Iddon is an independent Clinical Psychologist, Neuropsychologist and CBT therapist in Central London who assesses and treats patients with psychological issues (e.g. anxiety, depression, eating disorders) and neuropsychological disorders (with special interests in brain injury, dementia and hydrocephalus). Dr Iddon teaches and supervises as a Neuropsychology Consultant to the Oxleas NHS Mental Health Trust.

Professor Jan Malm,

Professor of Neurology, Department of Pharmacology and Clinical Neurosciences, University of UMEA, Sweden

Prof Malm has a high interest in Cerebrospinal Fluids Dynamics and in particular, hydrocephalus and idiopathic normal pressure hydrocephalus. Prof Malm has published on intra cranial pressure and on MRI and collaborates across specialities to generate evidence and advance patient care.

Professor Paul M. Parizel,

Professor of Radiology, Department of Radiology, Antwerp University Hospital, Belgium

Prof Parizel is Chairman of the Department of Radiology at Antwerp University Hospital and full Professor of Radiology at the Faculty of Medicine, University of Antwerp.
Prof Parizels’ main fields of interest are neuroradiology and MRI, with a focus on integrating basic science into clinical applications. He has received several national and international awards, including the prize of the European Society of Neuroradiology, the Award of the Belgian Government, the Kodak Grant of the Royal Belgian Society of Radiology.

Professor John D. Pickard,

Professor of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, UK

Professor Pickard is globally recognized for advancing the care of patients with acute brain injury (trauma, haemorrhage and hydrocephalus) from initial ictus, neurointensive care, recovery from coma and rehabilitation to final outcome through the study of pathophysiology (multimodality bedside monitoring, PET and MR imaging - Wolfson Brain Imaging Centre), randomised controlled trials, UK Shunt Evaluation Laboratory and Shunt Registry and refining the rehabilitation pathway for our 2.6M population in the Eastern Region.

Download Slides

Please login to download the slides

Key Learning Objectives

  • INPH Triad of symptoms: Dementia, Gait disturbance and Urinary incontinence.
  • iNPH patients are often diagnosed as Parkinson’s and Alzheimer’s patients. A well-interpreted MRI can help for a correct diagnosis.
  • Shunting for iNPH has been shown to be clinically effective and good outcome is possible.
  • A hydrocephalus shunt procedure for this condition has been shown to result in a cost saving of $184.3 million in Medicare expenditures over 5 years in the USA.

Audience

  • Neurosurgeon
  • Neurologist
  • Neuroradiologist
  • Neuropsychologist
  • Neuropsychiatrist
  • General Practioners
  • Memory Clinic Doctors
  • Geriatrician